Strategic Plan
Our Values: Excellence, Equity, Advocacy, Ethics & Diversity
We will work with stakeholders to champion pharmacy and pharmaceutical sciences to benefit patients and the wider community. The planning process, the resulting strategic actions, the mission and vision underpinning these are described in the following pages. The School is in a strong position with a wonderfully talented staff, exceptional students and an outstanding reputation. This strategic plan will enable us to consolidate our position, maximise our capacity, grow and develop to meet leadership and societal changes head on.
Strategic Advisory Board
The Strategic Advisory Board (SAB) was established in early 2015 to review and guide the strategy of the School of Pharmacy and Pharmaceutical Sciences, with a view to maintaining and building on internationally recognised excellence. It is composed of respected experts, whose names were proposed by the Head of School and then approved by the School Executive Committee.
The School’s current Strategic Advisory Board members are:

Dr. Aoife Brennan
Chief Executive Officer Synlogic Therapeutics

Mr. Patrick Byrne
Community Pharmacist Byrne's Life Pharmacy

Dr. Michele Cleary
Head US Scientific Collaborations Bristol Myers Squibb

Dr. Mark Ledwidge
Adjunct Professor School of Medicine University College Dublin

Dr. Mary McCarron
Professor at School of Nursing & Midwifery, Trinity College Dublin

Mr. Seamus Mulligan
Chairman & CEO Adapt Pharma

Mr. Paul Tighe
Head of Pharmacy Services St. Vincent's University Hospital